Provider

The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.

Also, Olympus has come up with the third-generation Visera Elite surgical visualisation platform for endoscopic procedures.

The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.

According to a survey by the American Medical Association, 93% of physicians felt there was some advantage or a definite advantage to using digital health tools in 2022, compared with 85% in 2016.

The merger between Lightbeam and CareSignal aims to assist more health systems improve patient engagement and population health, according to Lightbeam Health Solutions President Jerry Shultz and CareSignal CEO Blake Marggraff.

Healthcare institutions will be successful if they unite clinical medicine and data science, says Simon Philip Rost, CMO at GE Healthcare Enterprise Digital Solutions.

Matt Franklin, Akili Interactive's president and COO, explains the company's strategy for launching EndeavorRx, its video game digital therapeutic for children with ADHD.

First Databank president Bob Katter discusses the FDB Vela electronic prescribing network and how it will give patients with more control over their prescriptions.

Corinne Dive-Reclus, global head of lab insights business at Roche Diagnostics, explores the ways the company assists the healthcare industry by digitizing labs, connecting providers with actionable data and fostering innovation access.

National Minority Health Association executive director Burgess Harrison explains how the NMHA works to fix healthcare inequalities, with benefits to people and to businesses.